Search

Your search keyword '"Presley, Carolyn"' showing total 540 results

Search Constraints

Start Over You searched for: Author "Presley, Carolyn" Remove constraint Author: "Presley, Carolyn"
540 results on '"Presley, Carolyn"'

Search Results

51. Analysis of a Pilot Study Delivering Cancer Survivorship Education to Community Healthcare Professionals Utilizing the Project ECHO model

53. Reducing hospital admissions in patients with malignant pleural effusion: a quality improvement study

56. OR03-04-23 Improvement in Diet Quality Among Patients With Lung Cancer: Preliminary Results From a Medically Tailored Meals Plus Nutrition Counseling Intervention

59. Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

60. A cognitive–behavioral model of dyspnea: Qualitative interviews with individuals with advanced lung cancer.

61. Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer

62. Abstract 4435: A causal modeling platform for testing lifestyle interventions on the microbiome and response to immunotherapy

65. Cancer-related Fatigue in Lung Cancer: A Research Agenda: An Official American Thoracic Society Research Statement

66. Depression in association with neutrophil-to-lymphocyte, platelet-to-lymphocyte, and advanced lung cancer inflammation index biomarkers predicting lung cancer survival

71. Abstract A021: Older adult-specific microbes correlate with treatment response and markers of T-cell senescence in NSCLC

72. Abstract PR004: Older adult-specific microbes correlate with treatment response and markers of T-cell senescence in NSCLC

73. Patient Understanding of Tumor Genomic Testing: A Quality Improvement Effort

75. 442 Pre-treatment interstitial abnormalities is a risk factor for immune checkpoint inhibitor pneumonitis in patients with lung cancer

76. 585 Phase 1 dose escalation trial of the selective A2B adenosine receptor antagonist PBF-1129 in patients with metastatic non-small cell lung cancer (mNSCLC)

77. 1249 Treatment interruptions for immune related adverse events and overall survival in patients with non-small cell lung cancer (NSCLC) treated with first line immune checkpoint inhibitors (ICI)

79. Cancer and Aging

80. Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

81. Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

82. Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

83. Barriers to and recommendations for integrating the age‐friendly 4‐Ms framework into electronic health records.

86. Abstract 3523: A Black Raspberry dietary intervention to modify the gut microbiome and improve the response to immune checkpoint inhibitors

87. Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer

88. Aggressive End-of-Life Care in the Veterans Health Administration versus Fee-for-Service Medicare among Patients with Advanced Lung Cancer

91. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

92. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry

95. A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry

99. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial

Catalog

Books, media, physical & digital resources